EyePoint Pharmaceuticals
EYPT
$19.74
Share price
-1.00%
Change (1 day)
201.83%
Change (1 year)
Categories
EyePoint Pharmaceuticals (EYPT) - Cash on Hand
Cash on Hand as of December 2023 : $0.33 B
According to EyePoint Pharmaceuticals
's latest financial reports the company has $0.33 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
EyePoint Pharmaceuticals - Cash on Hand chart (from 2003 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.33 B | 129% |
| 2022-12-31 | $0.14 B | -31.67% |
| 2021-12-31 | $0.21 B | 371.08% |
| 2020-12-31 | $44.9 M | 102.17% |
| 2019-12-31 | $22.21 M | |
| 2018-06-30 | $38.77 M | 129.47% |
| 2017-06-30 | $16.89 M | -41.71% |
| 2016-06-30 | $28.99 M | 1.6% |
| 2015-06-30 | $28.53 M | 56.12% |
| 2014-06-30 | $18.27 M | 77.92% |
| 2013-06-30 | $10.27 M | -29.5% |
| 2012-06-30 | $14.57 M | -39.61% |
| 2011-06-30 | $24.12 M | 37.36% |
| 2010-06-30 | $17.56 M | 154.6% |
| 2009-06-30 | $6.89 M | -55.8% |
| 2008-06-30 | $15.6 M | 484.61% |
| 2007-06-30 | $2.67 M | -76.72% |
| 2006-06-30 | $11.46 M | 17.15% |
| 2005-06-30 | $9.79 M | -55.06% |
| 2004-06-30 | $21.78 M | 2647.88% |
| 2003-06-30 | $0.79 M | |
| 2001-06-30 | $1.64 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | $0.13 M | -99.96% | Bahamas |
 NRC Health
NRC | $6.65 M | -97.99% | 🇺🇸 USA |